TesoRx and Aspen Group Conclude Investment and Licensing Agreement

(Menlo Park, CA, United States and Grande Bay, Mauritius) October 20, 2014 – TesoRx Pharma, LLC, a specialty pharmaceutical company, announced today that it has licensed select international rights to TSX-002, the first unmodified oral-Testosterone replacement...

Armetheon Announces Close of $7M Series A Financing

The Locust Walk Partners team is proud to share with you today’s news that our client, Armetheon, Inc., completed its Series A financing, raising an over-subscribed Series A round of $7M.  The round was co-led by AshHill Biomedical Investments and Hercules Bioventures...

Senesco Completes Acquisition of Fabrus

Senesco Completes Acquisition of Fabrus Press Release May 19, 2014 8:30 am BRIDGEWATER, N.J.–(BUSINESS WIRE)– Senesco Technologies, Inc. (“Senesco” or the “Company”) (SNTI), completed its acquisition of Fabrus, Inc. (“Fabrus”), a biotechnology company...